New approaches in the treatment of non-small cell lung cancer: Taxanes in the treatment of NSCLC: pathways to progress

This publication has 13 references indexed in Scilit:

• Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
  New England Journal of Medicine, 2002
• Cancer Statistics, 2002
  CA: A Cancer Journal for Clinicians, 2002
• Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial
  Journal of Clinical Oncology, 2001
• Docetaxel (Taxotere) in combination with platinums in patients with non-small cell lung cancer: Trial data and implications for clinical management
  Seminars in Oncology, 2001
• Pathologic stage IIIb non-small cell lung cancer (NSCLC): Prolonged survival with consoloidation Docetaxel following concurrent chemoradiotherapy (SWOG 9504)
  Lung Cancer, 2000
• Early results of an international phase III study evaluating Taxotere as neo-adjuvant therapy for radically-treatable stage III NSCLC
  Lung Cancer, 2000
• Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimens
  Journal of Clinical Oncology, 2000
• Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
  Journal of Clinical Oncology, 2000
• A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC)
  Lung Cancer, 2000
• Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials
  BMJ, 1995